MarketResearch.biz delivers in-depth insights on the global point-of-care infectious disease diagnostics market in its upcoming report titled, “Global Point-of-Care Infectious Disease Diagnostics Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global point-of-care infectious disease diagnostics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global point-of-care infectious disease diagnostics market report has been segmented on the basis of product, mode of prescription, end user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Infectious diseases are generally a result of infection in an individual. Infectious disease diagnostics is the process of identifying presence of foreign antigen/organisms with the help of various diagnostic tools. Infectious diseases are generally spread through microorganisms such as parasites, fungi, and bacteria. It can also spread from one person to another, directly or indirectly. Point-of-care infectious disease diagnostic facilities are places wherein an individual can get proper diagnosis and treatment (up to a certain extent) without him/her having to visit a hospital or medical center.
High prevalence coupled with increasing incidence of infectious diseases are major factors driving growth of the global point-of-care infectious disease diagnostics market. In addition, technological advancements in point-of-care facilities, increasing presence of various diagnostic facilities in emerging economies, and growing awareness about infectious diseases are other major factors anticipated to boost growth of the global point-of-care infectious disease diagnostic market over the forecast period. Moreover, increasing government initiatives for support of point-of-care diagnostics facilities in emerging economies is another factor expected to propel growth of the global market over the forecast period.
However, high costs associated with setting up and maintaining proper functioning of point-of-care infectious disease diagnostics facilities, especially in emerging economies is a major factor restraining growth of the global market. Additionally, lack of awareness in some emerging economies and lack of skilled professionals at point-of-care diagnostic centers are other major factors projected to hamper growth of the global market over the forecast period.
Currently, the market in North America dominates the global point-of-care infectious disease diagnostics market in revenue terms owing to high prevalence of infectious diseases, increasing incidence of lifestyle related diseases, and increasing product approvals by government in the region. The market in Asia Pacific accounted for second-highest revenue share in the global point-of-care infectious disease diagnostics market, followed by markets in Europe, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is further projected to witness fastest growth in terms of revenue, owing to increasing government initiatives for improvement of healthcare facilities in emerging economies such as China and India in the region. Also, presence of a large patient pool coupled with growing awareness about infectious diseases in these countries are other factors anticipated to propel growth of the Asia Pacific market over the forecast period.
Global point-of-care infectious disease diagnostics market segmentation:
- Glucose monitoring kits
- Infectious disease testing kits
- Pregnancy and fertility testing kits
- Hematology testing kits
- Cardio metabolic monitoring kits
- Urinalysis Testing Kits
- Coagulation Monitoring Kits
- Tumor/Cancer Markers Testing Kits
- Drugs of Abuse Testing Kits
- Others (Calcium Assay Kits, Cholesterol Test Strips, Fecal Occult Testing Kits and Immunochemistry Kits)
By mode of prescription:
- Prescription based point of care diagnostics
- Over-the-counter (OTC) based point of care testing devices
By end user:
- Professional Diagnostic Centers
- Research Laboratories
- Home Care
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Abbott Laboratories
- Siemens AG
- Hoffmann-La Roche Ltd.
- Sinocare Inc.
- Johnson & Johnson
- Sysmex Corporation
- Nova Biomedical
- Danaher Corporation
- Becton Dickinson and Company
- bioMrieux SA
- Bio-Rad Laboratories
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!